Literature DB >> 5315979

Complication of methotrexate-maintained remission in lymphoblastic leukemia.

R G Rawbone, M T Shaw, J G Jackson, K D Bagshawe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5315979      PMCID: PMC1799639          DOI: 10.1136/bmj.4.5785.467

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Renal toxicity of methotrexate.

Authors:  P T Condit; R E Chanes; W Joel
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

2.  Pulmonary disease complicating intermittent therapy with methotrexate.

Authors:  A M Clarysse; W J Cathey; G E Cartwright; M M Wintrobe
Journal:  JAMA       Date:  1969-09-22       Impact factor: 56.272

3.  Liver damage due to methotrexate in patients with psoriasis.

Authors:  M G Dahl; M M Gregory; P J Scheuer
Journal:  Br Med J       Date:  1971-03-20
  3 in total
  4 in total

Review 1.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 2.  Smoking-related interstitial lung disease.

Authors:  Lars Hagmeyer; Winfried Randerath
Journal:  Dtsch Arztebl Int       Date:  2015-01-23       Impact factor: 5.594

Review 3.  Imaging of macrophage-related lung diseases.

Authors:  Katharina Marten; David M Hansell
Journal:  Eur Radiol       Date:  2005-01-05       Impact factor: 5.315

4.  Pulmonary toxicity of antineoplastic agents.

Authors:  M R Green
Journal:  West J Med       Date:  1977-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.